No price history available.
Key financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | MYRm | 13,400 | 17,129 | 17,989 | 20,935 | 24,383 | 25,745 | N/A | N/A |
| Operating profit | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | MYRm | 199 | 1,863 | 1,548 | 2,952 | 2,657 | 2,101 | N/A | N/A |
| EPS reported | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | MYRm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | MYR | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in MYR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
IHH Healthcare Berhad, established in Kuala Lumpur, Malaysia, in 2010, functions as a global investment holding company renowned for its comprehensive healthcare services. Its expansive operational footprint stretches across Malaysia, Singapore, Turkey, India, China, Japan, Europe, and other international markets. The company delivers a full spectrum of patient care, starting with primary services like routine check-ups, vaccinations, and treatment for common illnesses, and progressing to secondary care encompassing specialist consultations, minor surgeries, and emergency medical attention. It further provides advanced tertiary care, which includes specialized consultations, complex medical treatments, and inpatient services, alongside highly specialized quaternary care, featuring organ transplantation, neurosurgery, intricate cardiac procedures, and reconstructive plastic surgery. Beyond direct patient treatment, IHH Healthcare provides a wide array of supporting and operational services. These include advanced diagnostics, analytical laboratory testing, therapeutic radiology, and integrated rehabilitation, as well as advanced molecular diagnostics. The company is also a significant player in medical education, actively training nurses, doctors, and allied healthcare professionals. Its diverse operations extend to administrative, management, and consultancy services, various emergency and home care offerings (including orthopedic and ambulatory care), and the development of healthcare information systems and technology solutions. Furthermore, IHH Healthcare manages real estate investment trusts, operates specialized centers such as dialysis and treasury facilities, and establishes educational institutions for medical learning and research. It oversees the entire lifecycle of healthcare infrastructure, from developing and constructing facilities to their supervision, management, and leasing. Complementary services like hospital catering, laundry, and cleaning, alongside the import and wholesale of pharmaceuticals and medical materials, are also integral to its vast business portfolio. The company additionally engages in property letting and provides software system integration and application management services.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
IHH Healthcare Berhad, established in Kuala Lumpur, Malaysia, in 2010, functions as a global investment holding company renowned for its comprehensive healthcare services. Its expansive operational footprint stretches across Malaysia, Singapore, Turkey, India, China, Japan, Europe, and other international markets. The company delivers a full spectrum of patient care, starting with primary services like routine check-ups, vaccinations, and treatment for common illnesses, and progressing to secondary care encompassing specialist consultations, minor surgeries, and emergency medical attention. It further provides advanced tertiary care, which includes specialized consultations, complex medical treatments, and inpatient services, alongside highly specialized quaternary care, featuring organ transplantation, neurosurgery, intricate cardiac procedures, and reconstructive plastic surgery. Beyond direct patient treatment, IHH Healthcare provides a wide array of supporting and operational services. These include advanced diagnostics, analytical laboratory testing, therapeutic radiology, and integrated rehabilitation, as well as advanced molecular diagnostics. The company is also a significant player in medical education, actively training nurses, doctors, and allied healthcare professionals. Its diverse operations extend to administrative, management, and consultancy services, various emergency and home care offerings (including orthopedic and ambulatory care), and the development of healthcare information systems and technology solutions. Furthermore, IHH Healthcare manages real estate investment trusts, operates specialized centers such as dialysis and treasury facilities, and establishes educational institutions for medical learning and research. It oversees the entire lifecycle of healthcare infrastructure, from developing and constructing facilities to their supervision, management, and leasing. Complementary services like hospital catering, laundry, and cleaning, alongside the import and wholesale of pharmaceuticals and medical materials, are also integral to its vast business portfolio. The company additionally engages in property letting and provides software system integration and application management services.
